Related Experiment Video
Updated: May 23, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
Published on: August 29, 2015
A two-dimensional screen for AMPK substrates identifies tumor suppressor fumarate hydratase as a preferential AMPKα2
Anna Klaus1, Cécile Polge, Sarah Zorman
1Laboratory of Fundamental and Applied Bioenergetics, University Joseph Fourier, Grenoble Cedex 9, France.
Abstract:
AMP-activated protein kinase (AMPK) is emerging as a central cellular signaling hub involved in energy homeostasis and proliferation. The kinase is considered as a suitable target for pharmacological intervention in several energy-related pathologies like diabetes type II and cancer, although its signaling network is still incompletely understood. Here we apply an original two-dimensional in vitro screening approach for AMPK substrates that combines biophysical interaction based on surface plasmon resonance with in vitro phosphorylation. By enriching for proteins that interact with a specific AMPK isoform, we aimed to identify substrates that are also preferentially phosphorylated by this specific AMPK isoform. Application of this screen to full-length AMPK α2β2γ1 and soluble rat liver proteins identified the tumor suppressor fumarate hydratase (FH). FH was confirmed to interact with and to be preferentially phosphorylated by the AMPKα2 isoform by using yeast-two-hybrid and in vitro phosphorylation assays. AMPK-mediated phosphorylation of FH significantly increased enzyme activity in vitro and in vivo, suggesting that it is a bona fide AMPK substrate. In vivo, AMPKα2 is supposed to target the cytosolic/nuclear pools of FH, whose tumor suppressor function relies on DNA damage repair and inhibition of HIF-1α-signaling.
Insights
AMP-activated protein kinase (AMPK) phosphorylates the tumor suppressor fumarate hydratase (FH), enhancing its activity. This discovery offers new insights into cellular energy regulation and potential therapeutic targets for cancer and diabetes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- AMP-activated protein kinase (AMPK) is a key regulator of energy homeostasis and cellular proliferation.
- Understanding the complete AMPK signaling network is crucial for developing treatments for metabolic diseases like type II diabetes and cancer.
- Pharmacological targeting of AMPK holds promise, but requires a deeper knowledge of its substrates and regulatory mechanisms.
Purpose of the Study:
- To identify novel substrates of AMP-activated protein kinase (AMPK), specifically those phosphorylated by the AMPKα2 isoform.
- To investigate the functional consequences of AMPK-mediated phosphorylation on identified substrates.
- To elucidate the role of AMPK-regulated fumarate hydratase (FH) in cellular processes and disease.
Main Methods:
- A novel two-dimensional in vitro screening approach combining surface plasmon resonance (SPR) for interaction analysis and in vitro phosphorylation assays.
- Enrichment of proteins interacting with a specific AMPK isoform (AMPKα2β2γ1) to identify preferential substrates.
- Validation of substrate identification using yeast-two-hybrid assays and in vitro phosphorylation experiments.
- Assessment of enzyme activity changes upon phosphorylation in vitro and in vivo.
Main Results:
- The screening identified fumarate hydratase (FH), a known tumor suppressor, as a substrate of the AMPKα2 isoform.
- FH was confirmed to interact with and be preferentially phosphorylated by AMPKα2.
- AMPK-mediated phosphorylation significantly increased FH enzyme activity both in vitro and in vivo.
- Evidence suggests AMPKα2 targets cytosolic and nuclear FH, impacting DNA repair and HIF-1α signaling.
Conclusions:
- Fumarate hydratase (FH) is a direct substrate of AMP-activated protein kinase (AMPK), specifically the AMPKα2 isoform.
- Phosphorylation by AMPK enhances FH enzyme activity, suggesting a regulatory role in cellular metabolism and tumor suppression.
- This finding provides a mechanistic link between energy sensing by AMPK and the tumor suppressor functions of FH, relevant to cancer and metabolic disorders.
More Related Videos
08:03Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells
Published on: May 23, 2025
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...